Diversity and Connectivity in Progressing ADME Science: Novel Approaches and Emerging Technologies In Silico, In Vitro and In Vivo

In this 51st Drug Metabolism GRC we look forward to the challenges and opportunities of the next 50 years of absorption, distribution, metabolism, and elimination (ADME) science. Our world is no longer just small or large molecules, “medium molecules” and novel modalities are amongst the medicines of today and tomorrow and our ADME understanding, tools and techniques have and must continue to evolve. Our meeting focus will be on cutting-edge science and the importance of interconnectedness among ADME disciplines so that we fully tap into the potential of emerging technologies and novel approaches in discovering, developing, and safely using medicine from diverse modalities. The emphasis will be on the translation of advanced computation/in silico, in vitro and in vivo ADME data with mechanistic understanding through modelling & simulation to clinical and regulatory outcomes. What’s special about GRC meetings is that we connect people and ideas across our disciplines including industry, academia, and regulatory agencies. The collegial nature and opportunity to learn about and discuss unpublished research, share ideas, connect informally with both emerging and tenured ADME scientists in the beautiful New Hampshire countryside make this conference unique. At the 51st Drug Metabolism GRC we embrace the fact that together we are better, that with diversity of thought we can bring greater impact to the patients who need us to rigorously follow the science, think outside the box and connect our learning from bench to bedside and back.

Due to limited accommodations at this venue, guest housing is very limited. To request family/guest housing please reach out to your Conference Operations Associate.